Medication info
Lina Empa Tablet 10/5 mg (Empagliflozin, Linagliptin)

Lina Empa Tablet 10/5 mg (Empagliflozin, Linagliptin)

Prescription medicationTabletOral
Ingredient · strength
Linagliptin Micronized›5mg / 1 tabletEmpagliflozin›10mg / 1 tablet
Manufacturer / importer
Green Cross Corporation
Appearance
Pale yellow circular film-coated tablet
Packaging
PTP - 30 tablets/box [10 tablets/PTP x 3], bottle - 30 tablets/bottle, bottle - 100 tablets/bottle
Approval status
Active

MFDS item code 202402282 · Approved 2024.09.23

Summary

Main use
Improvement of blood glucose control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is well tolerated, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant empagliflozin and linagliptin therapy should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose of this medicine is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and resume the usual dosing schedule. Do not take a double dose in one day. Patients with renal impairment: This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients: No dose adjustment based on age is necessary. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Ingredients

Manufacturer
Green Cross Corporation

Efficacy & effects

Improvement of blood glucose control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to help control blood sugar levels in patients with type 2 diabetes by administering empagliflozin and linagliptin together. When taken alongside diet and exercise, it can effectively manage blood sugar levels. This leads to improved blood sugar control ability and a smoother management of diabetes for patients.

How to take

Adult dose

The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If additional glycemic control is needed and empagliflozin 10 mg/linagliptin 5 mg is well tolerated, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant empagliflozin and linagliptin therapy should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If a dose of this medicine is missed, take it as soon as remembered. However, if the next dose is due within 12 hours, skip the missed dose and resume the usual dosing schedule. Do not take a double dose in one day. Patients with renal impairment: This medicine is not recommended to improve glycemic control in patients with an estimated glomerular filtration rate (eGFR) below 45 ml/min/1.73m2. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Elderly patients: No dose adjustment based on age is necessary. In patients aged 75 years and older, renal function and the risk of volume depletion should be considered.

Precautions

This medication is a diabetes treatment containing both empagliflozin and linagliptin as ingredients. First, this medication should not be used by individuals allergic to empagliflozin, linagliptin, or any other ingredient contained in the drug, by patients with type 1 diabetes, diabetic ketoacidosis, or those undergoing kidney dialysis. Patients with impaired kidney function should regularly undergo kidney function tests before taking this medication. It is especially important to check kidney status at least once a year before starting the medication and during treatment. For patients with mild symptoms of heart failure, careful use is advised, while it is not recommended for patients with severe heart failure. While taking this medication, there is a risk of developing acute pancreatitis, so if symptoms such as abdominal pain or vomiting occur, prompt consultation with a physician is necessary. Additionally, a rare skin condition called bullous pemphigoid that causes blisters may occur, and any skin abnormalities should be reported immediately. The most common side effect is urinary tract infection, but other possible side effects include hypoglycemia, thirst, cough, constipation, itching, and rash. Particular caution is needed if this medication is taken alongside other blood sugar-lowering agents such as insulin or sulfonylureas due to the increased risk of hypoglycemia. Also, this medication may reduce the body's fluid levels, so elderly patients or those with cardiovascular disease who are at risk of dehydration or low blood pressure should exercise caution when taking it. Care is also needed while driving or operating machinery to reduce the risk of accidents due to hypoglycemia. Pregnant or breastfeeding women are advised to avoid taking this medication, especially during breastfeeding as it may transfer to the baby through breast milk, and discontinuing breastfeeding is recommended. Lastly, this medication is not recommended for use in children under 18 years old, as safety and efficacy have not been established. If any abnormal symptoms occur while taking this medication, immediate consultation with healthcare professionals is important, and regular check-ups to manage health status are crucial.

Side effects

  • Urinary tract infection
  • vulvovaginitis
  • vulvitis
  • balanitis
  • genital infections
  • hypersensitivity
  • angioedema
  • urticaria
  • hypoglycemia
  • thirst
Show 132 more
  • ketoacidosis
  • cough
  • constipation
  • pancreatitis
  • oral ulcer formation
  • itching
  • rash
  • vesicular pemphigoid
  • rhabdomyolysis
  • blood volume depletion
  • increased urination
  • dysuria
  • interstitial nephritis
  • increased amylase
  • increased lipase
  • elevated hematocrit
  • increased serum lipids
  • increased blood creatinine
  • nasopharyngitis
  • Fournier's gangrene
  • upper abdominal pain
  • enterocolitis
  • intestinal obstruction
  • gastroenteritis
  • herpes zoster
  • cystitis
  • acute pyelonephritis
  • bronchitis
  • vestibular neuronitis
  • sepsis
  • pneumonia
  • decreased appetite
  • dehydration
  • hyperglycemia
  • cerebral infarction
  • speech disorders
  • Alzheimer’s dementia
  • chest pain
  • fever
  • facial swelling
  • fatigue
  • death
  • chronic obstructive pulmonary disease
  • asthma
  • diabetic foot
  • skin lesions
  • rhabdomyolysis
  • blood volume depletion
  • acute kidney injury
  • end-stage renal disease
  • acute cholangitis
  • acute cholecystitis
  • cholangitis
  • hearing loss
  • dizziness
  • erectile dysfunction
  • goiter
  • kidney transplant failure
  • anemia
  • constipation
  • diarrhea
  • headache
  • insomnia
  • depression
  • hypertension
  • benign prostatic hyperplasia
  • vulvar pruritus
  • genital pruritus
  • dermal cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • circular eczema
  • hyperhidrosis
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • ocular discomfort
  • ocular congestion
  • pathological myopia
  • retinal detachment
  • retinal crystals
  • retinal vein occlusion
  • exudative retinal detachment
  • eyelid edema
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • nasal bleeding
  • exertional dyspnea
  • wet cough
  • allergic rhinitis
  • retained sputum
  • skin tear
  • rib fracture
  • ligamentous syndrome
  • angina
  • palpitations
  • Prinzmetal angina
  • coronary artery disease
  • tachycardia
  • atherosclerosis
  • deep vein thrombosis
  • diabetic vascular complications
  • peripheral arterial occlusive disease
  • anxiety
  • sleep disorders
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • hepatitis
  • ear pain
  • position-induced vertigo
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly sealed container to prevent exposure to air or moisture, and it is safe to store at room temperature between 1 and 30 degrees Celsius. Therefore, it is important to store it in an appropriate temperature and environment to maintain the medication's effectiveness.

Appearance and packaging

Appearance

Pale yellow circular film-coated tablet

Package unit

PTP - 30 tablets/box [10 tablets/PTP x 3], bottle - 30 tablets/bottle, bottle - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.